Ocular Therapeutix (OCUL) logo

OCUL earnings date, and what happened the last 4 times

Next report

Wed Nov 4

Quality Score today -7

Before the open, in 9 days. Expected: the company has not confirmed it.

OCUL closed higher after 2 of its last 4 reports. On average it closed +0.5% the session after a report.

The moment OCUL reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when OCUL reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after OCUL's last 4 reports

OCUL's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 3, 20262026 · Before open-9estimated+1.4%+2.8%
May 5, 20262026 · Before open-1estimated-4.4%-0.6%
Feb 5, 20262026 · Before open-6estimated+3.5%+4.2%
Nov 4, 20252025 · Before open2estimated-1.8%-4.5%
  • Aug 3, 2026, before the open: that session OCUL opened +1.4% and closed +2.8%, and five sessions on it stood +12.5%. Its Quality Score going in was -9 (Poor), estimated.
  • May 5, 2026, before the open: that session OCUL opened -4.4% and closed -0.6%, and five sessions on it stood -5.0%. Its Quality Score going in was -1 (Poor), estimated.
  • Feb 5, 2026, before the open: that session OCUL opened +3.5% and closed +4.2%, and five sessions on it stood +7.1%. Its Quality Score going in was -6 (Poor), estimated.
  • Nov 4, 2025, before the open: that session OCUL opened -1.8% and closed -4.5%, and five sessions on it stood -5.1%. Its Quality Score going in was 2 (Below Average), estimated.

Across these 4 reports OCUL opened higher after 2 of 4 and closed higher after 2 of 4; on average it opened -0.3%, closed +0.5%, and stood +2.4% five sessions on. Its Quality Score is -7 today, against -9 going into its Aug 3, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -4.5% after the Nov 4, 2025 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see OCUL's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about OCUL's earnings

As of Oct 26, 2026: Ocular Therapeutix (OCUL): expected to report Wed Nov 4, before the open. OCUL closed higher after 2 of its last 4 reports. Its Quality Score is -7 (Poor). Scores as of 10:16 PM ET, 15 minutes behind.

When is OCUL's next earnings date?

Expected to report Wed Nov 4, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. OCUL closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does OCUL report before or after the market?

OCUL is expected to report Wed Nov 4, before the open. Its last 4 reports came before the open.

How did OCUL stock react to its last earnings report?

Aug 3, 2026, before the open: that session OCUL opened +1.4% and closed +2.8%, and five sessions on it stood +12.5%.

Does OCUL stock usually go up after earnings?

OCUL closed higher after 2 of its last 4 reports. On average it closed +0.5% the session after a report, after opening -0.3%. Past behavior, not a forecast.

Ocular Therapeutix's page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.